- Home
- GWAV vs IBIO Comparison
GWAV vs IBIO Comparison
Compare GWAV & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWAV
- IBIO
- Stock Information
- Founded
- GWAV 2002
- IBIO 2008
- Country
- GWAV United States
- IBIO United States
- Employees
- GWAV N/A
- IBIO N/A
- Industry
- GWAV Packaged Foods
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GWAV Consumer Staples
- IBIO Health Care
- Exchange
- GWAV Nasdaq
- IBIO Nasdaq
- Market Cap
- GWAV 12.8M
- IBIO 11.9M
- IPO Year
- GWAV N/A
- IBIO N/A
- Fundamental
- Price
- GWAV $0.19
- IBIO $0.59
- Analyst Decision
- GWAV
- IBIO Strong Buy
- Analyst Count
- GWAV 0
- IBIO 2
- Target Price
- GWAV N/A
- IBIO $5.50
- AVG Volume (30 Days)
- GWAV 1.8M
- IBIO 432.7K
- Earning Date
- GWAV 08-18-2025
- IBIO 09-19-2025
- Dividend Yield
- GWAV N/A
- IBIO N/A
- EPS Growth
- GWAV N/A
- IBIO N/A
- EPS
- GWAV N/A
- IBIO N/A
- Revenue
- GWAV $33,315,859.00
- IBIO $375,000.00
- Revenue This Year
- GWAV N/A
- IBIO $81.33
- Revenue Next Year
- GWAV N/A
- IBIO N/A
- P/E Ratio
- GWAV N/A
- IBIO N/A
- Revenue Growth
- GWAV N/A
- IBIO 650.00
- 52 Week Low
- GWAV $0.12
- IBIO $0.56
- 52 Week High
- GWAV $1.09
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- GWAV 40.58
- IBIO 26.08
- Support Level
- GWAV $0.19
- IBIO $0.56
- Resistance Level
- GWAV $0.22
- IBIO $0.78
- Average True Range (ATR)
- GWAV 0.02
- IBIO 0.03
- MACD
- GWAV -0.01
- IBIO -0.01
- Stochastic Oscillator
- GWAV 4.86
- IBIO 11.95
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.